Part 23
The Frontier: Regenerative Medicine
Picture a clinic in a resort town abroad. The website shows a waterfall and a smiling physician. For $25,000 it offers stem cells “for anti-aging,” delivered by intravenous drip, with a massage afterward. There is no published trial, no follow-up, and no one to call when you get home with a fever. The frontier of longevity science is thrilling. It is also where desperate and hopeful people get hurt.
Clinical scenes in this edition are explicitly labeled illustrations. They describe imagined situations used to explain medical decisions, not documented patients, diagnoses, conversations, or treatment outcomes. They should not be read as evidence that a particular intervention works. Personal recollections are recollections, not medical records.
Evidence grade (draft mapping). 6 questions; a question with mixed evidence counts under each grade.
- 349. What is cellular reprogramming, and why is it the biggest idea in the field?It is a way of resetting a cell’s age markers to a younger state without changing what kind of cell it is. If it works safely in people, it would be the first true rejuvenation therapy.DPreclinical / mechanistic
- 350. Has reprogramming been tried in humans?Yes, for the first time, in June 2026. It is a small safety study in the eye. Results are not yet known.BLimited or small human studies
- 351. Do stem cell treatments reverse aging?No. Outside of a few approved uses such as bone marrow transplant for blood cancers, stem cell treatments are unproven, and some have caused serious harm.FNot demonstrated / insufficient
- 352. What are exosomes?Tiny packets that cells release to send signals to each other. They are scientifically interesting. There are no FDA-approved exosome products, and injected ones have caused infections.FNot demonstrated / insufficient
- 353. Does “young blood” or plasma exchange work?Infusing young people’s plasma has no proven benefit, and the FDA has warned against it. Plasma exchange, which removes and replaces part of your own plasma, is being studied seriously but is not ready.BLimited or small human studies
- 354. What will artificial intelligence do for longevity?In the near term, it will help read scans, predict risk, and find drug candidates faster. It will not replace the basics, and it will not replace a doctor who knows you.BLimited or small human studies